Is histologic remission in ulcerative colitis ready for prime time?

被引：3
|
作者：
Guardiola, Jordi [1 ]
Arajol, Claudia [1 ]
Armuzzi, Alessandro [2 ]
机构：
[1] Hosp Univ Bellvitge IDIBELL, Dept Digest Dis, Barcelona, Spain
[2] Fdn Policlin Gemelli Univ Cattolica, IBD Unit, Presidio Columbus, Rome, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2017年 / 49卷 / 12期
关键词：
Deep remission; Histologic remission; Calprotectin; Endoscopic remission; Mucosal healing; Treat to target; CLINICAL REMISSION; RISK-FACTOR; INFLAMMATION; RELAPSE; NEOPLASIA; DISEASE; LEVEL;
D O I：
10.1016/j.dld.2017.09.130
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1334 / 1335
页数：2
相关论文
共 50 条
  • [1] Adalimumab in ulcerative colitis: Ready for prime time
    Danese, Silvio
    [J]. DIGESTIVE AND LIVER DISEASE, 2013, 45 (01) : 8 - 13
  • [2] Early Intervention in Ulcerative Colitis: Ready for Prime Time?
    Solitano, Virginia
    D'Amico, Ferdinando
    Zacharopoulou, Eirini
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) : 1 - 12
  • [3] Histologic Remission in Ulcerative Colitis: Are We There Yet?
    Long, Millie D.
    Rubin, David T.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (05): : 713 - 715
  • [4] Histologic Remission: The Ultimate Therapeutic Goal in Ulcerative Colitis?
    Peyrin-Biroulet, Laurent
    Bressenot, Aude
    Kampman, Wendy
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (06) : 929 - +
  • [5] Histologic Markers of Inflammation in Patients With Ulcerative Colitis in Clinical Remission
    Rosenberg, Laura
    Nanda, Kavinderjit S.
    Zenlea, Talia
    Gifford, Anne
    Lawlor, Garrett O.
    Falchuk, Kenneth R.
    Wolf, Jacqueline L.
    Cheifetz, Adam S.
    Goldsmith, Jeffrey D.
    Moss, Alan C.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (08) : 991 - 996
  • [6] Review article: faecal calprotectin and histologic remission in ulcerative colitis
    D'Amico, Ferdinando
    Bonovas, Stefanos
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (07) : 689 - 698
  • [7] Histologic improvement predicts endoscopic remission in patients with ulcerative colitis
    Kim, Ji Eun
    Kim, Minjee
    Kim, Min-Ji
    Kim, Eun Ran
    Hong, Sung Noh
    Chang, Dong Kyung
    Ha, Sang Yun
    Kim, Young-Ho
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [8] Cyclosporine Enema in Conventional ± Immunomodulator Refractory Distal Ulcerative Colitis: Ready for Prime Time or Hype?
    Mahesh, Venkataswamy N.
    Campbell, Rachel
    Ahluwalia, Navneet K.
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S700 - S700
  • [9] CYCLOSPORINE ENEMA IN CONVENTIONAL ± IMMUNOMODULATOR REFRACTORY DISTAL ULCERATIVE COLITIS: READY FOR PRIME TIME OR HYPE
    Mahesh, V. N.
    Campbell, R.
    Ahluwalia, N. K.
    [J]. GUT, 2009, 58 : A44 - A44
  • [10] Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission
    Narula, Neeraj
    Aruljothy, Achuthan
    Alshahrani, Abdul-Aziz
    Fadida, Ma'ayan
    Al-Saedi, Mona
    Marshall, John K.
    Rubin, David T.
    Christensen, Britt
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (11-12) : 1676 - 1682
12345